Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
about
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLDNonalcoholic fatty liver disease as a multi-systemic diseaseUric acid in metabolic syndrome: From an innocent bystander to a central playerPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenThe role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver diseaseAssociation between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesisSerum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese menCytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis.The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective StudiesAssociation between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.Extrahepatic Manifestations of Nonalcoholic Fatty Liver DiseaseOral fructose absorption in obese children with non-alcoholic fatty liver diseaseAssociation of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease.Association between Serum Uric Acid and Elevated Alanine Aminotransferase in the General Population.Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.Non-alcoholic fatty liver disease: factors associated with its presence and onset.Pharmacological agents for nonalcoholic steatohepatitis.Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study.Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candiPrevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.Association of Visceral Fat and Liver Fat With Hyperuricemia.Serum Uric Acid and Impaired Glucose Tolerance: The Cardiometabolic Risk in Chinese (CRC) Study.The rate of production of uric acid by hepatocytes is a sensitive index of compromised cell ATP homeostasis.Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adultsEpicardial fat thickness and nonalcoholic fatty liver disease in obese subjects.Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway.Novel Insights in the Metabolic Syndrome in Childhood and Adolescence.Uric acid and obesity-related phenotypes in postmenopausal women.Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.New insights into NAFLD and Subclinical Coronary Atherosclerosis.A rapid and high-throughput method for the determination of serum uric acid based on microarray technology and nanomaterial.
P2860
Q26748461-5A1E9EE8-22D0-444E-A561-93BB04EBFF8DQ26749290-6F1402E3-B3AA-4A30-824A-C564B4E1297EQ26772053-3A2D027B-191E-4EB1-89F1-07E23D337263Q26861095-537A5FCD-4A3A-44C8-8BDE-C33B05F603F6Q27016052-EA7DBBC6-0E2A-41D1-AEA9-7F531FD1145FQ33693601-27203774-45CF-4787-BFAB-F4D0D45DFADAQ33886918-1348513C-6A25-438C-B54A-9998290158E6Q34917717-6685C9BE-EEAA-4ED0-8900-920E9AEDF7C4Q35064093-78582B0C-3FF0-44BB-90A8-59A59385653FQ35927066-D816E3E9-CE05-4832-BE1F-6E398F08EC0FQ36099467-C5B22CE4-06AB-499A-BD21-D54D19CE5741Q36153675-03781960-5DE9-487F-83E9-745FA228CF7EQ36418940-9B1CE9A6-CE08-4601-BC33-739333542EC9Q36921610-3DC0CE9F-0D02-40A2-A22E-679E3A34A824Q37104071-4ABB5BFA-27B0-4E79-8318-D7AF13D1EA74Q37106734-8AD21202-4AC3-40DF-B1B5-D1D172216826Q37283588-7AAC536B-C8FE-4DC8-96D2-CC89A718352DQ37479795-3902D9ED-F8B9-4A44-8086-67309D63F230Q38164074-BEF23386-C139-44AD-BE8F-453BDA504E2FQ38552387-2FE67CD0-DE39-4CDD-9EFB-320F1CB70F7DQ38595252-4027F949-1D5D-43D7-A8BE-DF374083030BQ38670507-9F186B18-6219-427B-BA4E-0A65C90B2517Q38843947-C13CB6EE-247A-4F04-B55F-64FC9CF71ABAQ39021862-07B46D9F-2A51-481B-8E90-17AF156DDAF7Q40088550-AB0A47DE-270F-4F33-A42A-EEB6EECB9611Q40211159-BAC825EC-FC3B-4129-B6C6-9D792774C582Q40678269-042B6A31-12CA-4481-9B00-A6490A6FAAD3Q41111925-6BBE1A08-5AF7-49E4-81D6-876AFBF5085CQ41209147-6A91E7F8-9713-4711-A1A5-19706FF3B545Q41298092-9B061C69-3EE1-40F5-9CC9-54D5E53BCAC5Q41365116-6A360AE8-6297-43A3-8056-39D7E281998FQ42445026-B71DEC65-B132-473F-89F8-CD2D96E3B1E4Q42577349-12F3F1A5-7DC2-4BC5-A199-CC931A05493CQ43603019-40085822-EFBB-4821-87F3-8085A9BCD0E5Q45141589-7706E7A2-3ACD-4235-94A7-645DDDC571F7Q47692391-048DD596-CB1C-49BC-BABA-21E3E9CF6867Q50093868-318A66A2-02B9-4AF7-A200-5C2E5B3D0801Q50147806-79304F77-C74E-4315-93CC-9FE325B5EAD4Q50148682-1DDB7648-A136-444E-9A97-10FB3D795FBEQ51097743-EF43C8DA-76D5-4446-828D-119641CE53A9
P2860
Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Elevated serum uric acid level ...... Nutrition Examination Survey.
@ast
Elevated serum uric acid level ...... Nutrition Examination Survey.
@en
type
label
Elevated serum uric acid level ...... Nutrition Examination Survey.
@ast
Elevated serum uric acid level ...... Nutrition Examination Survey.
@en
prefLabel
Elevated serum uric acid level ...... Nutrition Examination Survey.
@ast
Elevated serum uric acid level ...... Nutrition Examination Survey.
@en
P2093
P2860
P1433
P1476
Elevated serum uric acid level ...... Nutrition Examination Survey.
@en
P2093
Diana I Jalal
Giovanni Targher
Jeffrey C Sirota
Kim McFann
Michel Chonchol
Richard J Johnson
P2860
P304
P356
10.1016/J.METABOL.2012.08.013
P577
2012-10-02T00:00:00Z